Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 7
2007 1
2008 1
2010 1
2011 1
2012 1
2019 2
2020 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.
Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, Silva CAC, Terrisse S, Bonvalet M, Scherpereel A, Pegliasco H, Richard C, Ghiringhelli F, Elkrief A, Desilets A, Blanc-Durand F, Cumbo F, Blanco A, Boidot R, Chevrier S, Daillère R, Kroemer G, Alla L, Pons N, Le Chatelier E, Galleron N, Roume H, Dubuisson A, Bouchard N, Messaoudene M, Drubay D, Deutsch E, Barlesi F, Planchard D, Segata N, Martinez S, Zitvogel L, Soria JC, Besse B. Derosa L, et al. Among authors: bouchard n. Nat Med. 2022 Feb;28(2):315-324. doi: 10.1038/s41591-021-01655-5. Epub 2022 Feb 3. Nat Med. 2022. PMID: 35115705 Free PMC article.
Synephrine is not Neo-Synephrine.
Bouchard N, Hoffman RS. Bouchard N, et al. Mayo Clin Proc. 2004 Dec;79(12):1589-90; author reply 1590; discussion 1590. doi: 10.4065/79.12.1589-b. Mayo Clin Proc. 2004. PMID: 15595351 No abstract available.
Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes.
Couëtoux du Tertre M, Marques M, Tremblay L, Bouchard N, Diaconescu R, Blais N, Couture C, Pelsser V, Wang H, Higenell V, Izzi L, Gambaro K, Hoffert C, Srivastava A, Spatz A, Rousseau C, McNamara S, Cohen V, Batist G, Agulnik J. Couëtoux du Tertre M, et al. Among authors: bouchard n. Mol Cancer Ther. 2019 Sep;18(9):1628-1636. doi: 10.1158/1535-7163.MCT-19-0105. Epub 2019 Jun 26. Mol Cancer Ther. 2019. PMID: 31243098 Clinical Trial.
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.
Tonneau M, Phan K, Manem VSK, Low-Kam C, Dutil F, Kazandjian S, Vanderweyen D, Panasci J, Malo J, Coulombe F, Gagné A, Elkrief A, Belkaïd W, Di Jorio L, Orain M, Bouchard N, Muanza T, Rybicki FJ, Kafi K, Huntsman D, Joubert P, Chandelier F, Routy B. Tonneau M, et al. Among authors: bouchard n. Front Oncol. 2023 Jul 20;13:1196414. doi: 10.3389/fonc.2023.1196414. eCollection 2023. Front Oncol. 2023. PMID: 37546399 Free PMC article.
Descriptive Analysis of First-Line Non-Small Cell Lung Cancer Treatment with Pembrolizumab in Tumors Expressing PD-L1 ≥ 50% in Patients Treated in Quebec's University Teaching Hospitals (DALP-First Study).
Bérard G, Guévremont C, Marcotte N, Schroeder C, Bouchard N, Rajan R; Programme de Gestion Thérapeutique des Médicaments (PGTM). Bérard G, et al. Among authors: bouchard n. Curr Oncol. 2023 Mar 11;30(3):3251-3262. doi: 10.3390/curroncol30030247. Curr Oncol. 2023. PMID: 36975460 Free PMC article.
Carvedilol overdose with quantitative confirmation.
Bouchard NC, Forde J, Hoffman RS. Bouchard NC, et al. Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):102-3. doi: 10.1111/j.1742-7843.2008.00269.x. Basic Clin Pharmacol Toxicol. 2008. PMID: 18598302 Free article.
Treatment of delirium tremens.
Bouchard NC, Meltzer A, Hoffman RS. Bouchard NC, et al. Arch Intern Med. 2005 Mar 14;165(5):587; author reply 587. doi: 10.1001/archinte.165.5.587-a. Arch Intern Med. 2005. PMID: 15767540 No abstract available.
Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition.
Couëtoux du Tertre M, Marques M, McNamara S, Gambaro K, Hoffert C, Tremblay L, Bouchard N, Diaconescu R, Blais N, Couture C, Pelsser V, Wang H, McIntosh L, Hindie V, Parent S, Cortes L, Breton YA, Pottiez G, Croteau P, Higenell V, Izzi L, Spatz A, Cohen V, Batist G, Agulnik J. Couëtoux du Tertre M, et al. Among authors: bouchard n. Clin Proteomics. 2020 Feb 7;17:5. doi: 10.1186/s12014-020-9269-6. eCollection 2020. Clin Proteomics. 2020. PMID: 32055239 Free PMC article.
[Vaccination schedule].
Bouchard N, Landry M. Bouchard N, et al. Perspect Infirm. 2005 Jan-Feb;2(3):24-5. Perspect Infirm. 2005. PMID: 15686206 French. No abstract available.
18 results